Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

Hartman, Zachary C., Appledorn, Daniel M., Amalfitano, Andrea·2008·Virus Research

Cited by (239)

Items 101–200 of 239

  1. Experimental gene transfer to the corneal endothelium
    Daniel Kampik, Robin R. Ali, Frank Larkin · 2011 · Experimental Eye Research
  2. Overexpression of Notch ligand Delta-like-1 by dendritic cells enhances their immunoregulatory capacity and exerts antiallergic effects on Th2-mediated allergic asthma in mice
    Chen‐Chen Lee, Chu-Lun Lin, Sy‐Jye Leu, Yueh‐Lun Lee · 2017 · Clinical Immunology
  3. Retrograde axonal transport property of adeno-associated virus and its possible application in future
    Jingjing Wang, Liqin Zhang · 2021 · Microbes and Infection
  4. A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
    José Manuel Rojas, Noemı́ Sevilla, Verónica Martı́n · 2021 · Frontiers in Veterinary Science
  5. Metallic micro-ring device for highly efficient large cargo delivery in mammalian cells using infrared light pulses
    Ashwini Surendra Shinde, Pallavi Shinde, Srabani Kar, Kavitha Illath, Souvik Dey, Nitish R. Mahapatra, Moeto Nagai, Tuhin Subhra Santra · 2023 · Lab on a Chip
  6. Improving Adenovirus Based Gene Transfer: Strategies to Accomplish Immune Evasion
    Sergey S. Seregin, Andrea Amalfitano · 2010 · Viruses
  7. Biodistribution and Safety Profile of Recombinant Adeno-Associated Virus Serotype 6 Vectors following Intravenous Delivery
    Daniel Stone, Ying Liu, Zong-Yi Li, Robert Strauss, Eric E. Finn, James M. Allen, Jeffrey S. Chamberlain, André Lieber · 2008 · Journal of Virology
  8. β-Arrestins modulate Adenovirus-vector-induced innate immune responses: Differential regulation by β-arrestin-1 and β-arrestin-2
    Sergey S. Seregin, Daniel M. Appledorn, Sonika Patial, Matthew Bujold, William Nance, Sarah Godbehere, Narayanan Parameswaran, Andrea Amalfitano · 2009 · Virus Research
  9. Wide Awake and Ready to Move: 20 Years of Non-Viral Therapeutic Genome Engineering with the Sleeping Beauty Transposon System
    Russ Hodge, Suneel A. Narayanavari, Zsuzsanna Izsvák, Zoltán Ivics · 2017 · Human Gene Therapy
  10. Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
    Jianfeng Zhang · 2012 · Viruses
  11. MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8+ T lymphocytes
    Érica Araújo Mendes, Bráulia Costa Caetano, Marcus L. O. Penido, Oscar Bruña–Romero, Ricardo T. Gazzinelli · 2011 · Vaccine
  12. Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases
    Jianfeng Zhang, E. Bart Tarbet, Haroldo Toro, De-chu Christopher Tang · 2011 · Expert Review of Vaccines
  13. Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza
    Jianfeng Zhang, E. Bart Tarbet, Tsungwei Feng, Zhongkai Shi, Kent R. Van Kampen, De-chu Christopher Tang · 2011 · PLoS ONE
  14. Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy
    Ruiyang Yan, Andrew Hallam, Peter G. Stockley, Joan Boyes · 2014 · Biochemical Journal
  15. Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
    Yasser Ali Aldhamen, Sergey S. Seregin, Andrea Amalfitano · 2011 · Frontiers in Immunology
  16. Physical transfection technologies for macrophages and dendritic cells in immunotherapy
    Aranit Harizaj, Stefaan C. De Smedt, Ine Lentacker, Kevin Braeckmans · 2020 · Expert Opinion on Drug Delivery
  17. CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies
    Sergey S. Seregin, Yasser Ali Aldhamen, Dan Appledorn, Nathaniel J. Schuldt, A J McBride, M Bujold, Sarah Godbehere, Andrea Amalfitano · 2009 · Gene Therapy
  18. Challenges of bacteriophages application in controlling bacterial plant diseases and how to overcome them
    Esraa M. Halawa · 2023 · Journal of Genetic Engineering and Biotechnology
  19. Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters
    Baoling Ying, Károly Tóth, Jacqueline F. Spencer, Rajeev Aurora, William S.M. Wold · 2015 · Virology
  20. Virally mediated gene manipulation in the adult CNS
    Efrat Edry, Raphael Lamprecht, Shlomo Wagner, Kobi Rosenblum · 2011 · Frontiers in Molecular Neuroscience
  21. Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation
    Mohammad Fayyad‐Kazan, Sarah Ayad Al-Tameemi, Allal Ouhtit · 2026 · Cells
  22. Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines
    Anthony M. Marchese, Louis F Fries, Hadi Beyhaghi, Muruga Vadivale, Mingzhu Zhu, Shane Cloney-Clark, Joyce S. Plested, Amy W. Chung, Lisa M. Dunkle, Raj Kalkeri · 2024 · Journal of Infection
  23. Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices
    Sandra S. Renteria, Courtney C. Clemens, Maria A. Croyle · 2009 · Vaccine
  24. Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery
    Laura García‐García, Sergio Recalde, María Hernández, Jaione Bezunartea, Juan R. Rodríguez-Madoz, Sandra Johnen, Sabine Diarra, Corinne Marie, Zsuzsanna Izsvák, Zoltán Ivics et al. · 2017 · Molecular Therapy — Nucleic Acids
  25. Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
    Mariangela Garofalo, Monika Staniszewska, Stefano Salmaso, Paolo Caliceti, Katarzyna Wanda Pancer, Magdalena Wieczorek, Łukasz Kuryk · 2020 · Vaccines
  26. Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cells
    Benjamin H. Lee, Rahul Kushwah, Jing Wu, Philip Ng, Nades Palaniyar, Sergio Grinstein, Dana J. Philpott, Jim Hu · 2010 · Immunology Letters
  27. Ultrathin SU-8 membrane for highly efficient tunable cell patterning and massively parallel large biomolecular delivery
    Pallavi Shinde, Ashwini Surendra Shinde, Srabani Kar, Kavitha Illath, Moeto Nagai, Fan‐Gang Tseng, Tuhin Subhra Santra · 2023 · Lab on a Chip
  28. The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity
    Açelya Yılmazer, Wafa’ T. Al-Jamal, Jeroen Van den Bossche, Kostas Kostarelos · 2012 · Biomaterials
  29. Gene- and Viral-Based Therapies for Brain Tumors
    Kaveh Asadi-Moghaddam, Ennio Antonio Chiocca · 2009 · Neurotherapeutics
  30. Vaccine Platforms Combining Circumsporozoite Protein and Potent Immune Modulators, rEA or EAT-2, Paradoxically Result in Opposing Immune Responses
    Nathaniel J. Schuldt, Yasser Ali Aldhamen, Daniel M. Appledorn, Sergey S. Seregin, Youssef A. Kousa, Sarah Godbehere, Andrea Amalfitano · 2011 · PLoS ONE
  31. The Role of Endosomal Escape and Mitogen-Activated Protein Kinases in Adenoviral Activation of the Innate Immune Response
    Jeffrey S. Smith, Zhili Xu, Jie Tian, Donna J Palmer, Philip Ng, Andrew P. Byrnes · 2011 · PLoS ONE
  32. Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a “humanized” transgenic mouse model of type 1 diabetes
    Shahnawaz Imam, Raghavendra G. Mirmira, Juan Carlos Jaume · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  33. A prime–boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus
    Yuan-Hui Fu, Jinsheng He, Xiaobo Wang, Xianxian Zheng, Qiang Wu, Can Xie, Mei Zhang, Wei Wei, Qian Tang, Jingdong Song et al. · 2010 · Biochemical and Biophysical Research Communications
  34. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
    Kathleen A. McGuire, Kazutoyo Miura, Christopher M. Wiethoff, Kim C. Williamson · 2017 · Malaria Journal
  35. Recent advances in gene therapy: genetic bullets to the root of the problem
    Mohsen Danaeifar · 2022 · Clinical and Experimental Medicine
  36. pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects
    Abdus Faham, Thomas P. Herringson, Christopher Richard Parish, Andreas Suhrbier, Alexander A. Khromykh, Joseph G. Altin · 2011 · Vaccine
  37. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice
    Xiuzhen Li, Lin Li Lv, Xu Zhang, Kenneth Yongabi Anchang, Auwalu Yusuf Abdullahi, Liqing Tu, Xiaohu Wang, Lijun Xia, Xiu‐Xiang Zhang, Weili Feng et al. · 2016 · Infection Genetics and Evolution
  38. Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem
    Maria A. Croyle · 2009 · Expert Opinion on Drug Metabolism & Toxicology
  39. Enhancement of Cytotoxic T-lymphocyte Response in Aged Mice by a Novel Treatment with Recombinant AdIL-12 and Wild-type Adenovirus in Rapid Succession
    Jian Chen, John Wang, Jun Li, Qi Wu, Fei Chu Lim, PingAr Yang, Hui‐Chen Hsu, David T. Curiel, John D. Mountz · 2008 · Molecular Therapy
  40. p53-targeted cancer pharmacotherapy: move towards small molecule compounds
    Soo-Hyun Kim, Crispin R. Dass · 2011 · Journal of Pharmacy and Pharmacology
  41. Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development
    Elizabeth G. Rhee, Dan H. Barouch · 2009 · Clinical & Experimental Immunology
  42. Stimulation of Innate Immunity byIn VivoCyclic di-GMP Synthesis Using Adenovirus
    Benjamin J. Koestler, Sergey S. Seregin, David P. W. Rastall, Yasser Ali Aldhamen, Sarah Godbehere, Andrea Amalfitano, Christopher M. Waters · 2014 · Clinical and Vaccine Immunology
  43. Microbubble-mediated delivery of human adenoviruses does not elicit innate and adaptive immunity response in an immunocompetent mouse model of prostate cancer
    Flavia De Carlo, Litty Thomas, Bell Brooke, Elliot T. Varney, Rounak Paramjeet Nande, Olivia Boskovic, Gailen D. Marshall, Pier Paolo Claudio, Candace M. Howard · 2019 · Journal of Translational Medicine
  44. Specific long‐term changes in anti‐SARS‐CoV‐2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines
    Sebastian Reinig, Chin Kuo, Chia‐Chun Wu, Sheng‐Yu Huang, Jau‐Song Yu, Shin‐Ru Shih · 2024 · Journal of Medical Virology
  45. Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum
    Thomas W. Böldicke, Stefan Somplatzki, Galina Sergeev, Peter P. Mueller · 2011 · Methods
  46. Transduction of PEP-1–Heme Oxygenase-1 Fusion Protein Reduces Myocardial Ischemia/Reperfusion Injury in Rats
    Xianghu He, Yun Wang, Xuetao Yan, Yanlin Wang, Chengyao Wang, Zongze Zhang, Hui Li, Hai-Xing Jiang · 2013 · Journal of Cardiovascular Pharmacology
  47. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice
    H Saida, Y Matsuzaki, Kiyohiko Takayama, Akira Iizuka, Ayumu Konno, Shigeru Yanagi, Hirokazu Hirai · 2014 · Gene Therapy
  48. Expression of Concern: Adenovirus‐mediated expression of truncated E2F‐1 suppresses tumor growth in vitro and in vivo
    Jorge G. Gómez-Gutiérrez, Aracely García‐García, Hongying Hao, Xiao‐Mei Rao, Roberto Montes‐de‐Oca‐Luna, Heshan Sam Zhou, Kelly M. McMasters · 2010 · Cancer
  49. Making gene therapy for osteosarcoma a reality
    Matthew L. Broadhead, Jonathan C. M. Clark, Peter Choong, Crispin R. Dass · 2010 · Expert Review of Anticancer Therapy
  50. Adenovirus Vectors for Renal-Targeted Gene Delivery
    Daniel M. Appledorn, Sergey S. Seregin, Andrea Amalfitano · 2008 · KARGER eBooks
  51. Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses
    Horng-Tay Tzeng, Ping‐Ning Hsu, Pei‐Jer Chen · 2013 · Journal of Gastroenterology and Hepatology
  52. Use of DAF-Displaying Adenovirus Vectors Reduces Induction of Transgene- and Vector-Specific Adaptive Immune Responses in Mice
    Sergey S. Seregin, Yasser Ali Aldhamen, Daniel M. Appledorn, Jennifer Zehnder, Tyler T. Voss, Sarah Godbehere, Andrea Amalfitano · 2011 · Human Gene Therapy
  53. ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS
    Amanda Malefyt, S. Patrick Walton, Christina Chan · 2012 · Nano LIFE
  54. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS
    Bernard Klonjkowski, Dieter Klein, Sandra Galea, Françoise Gavard, Martine Monteil, Lidia Duarte, Annie Fournier, Sophie Sayon, Kamila Górna, Reinhard Ertl et al. · 2008 · Vaccine
  55. Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques
    Thorsten Demberg, Egidio Brocca‐Cofano, Seraphin Kuate, Stanley Aladi, Diego A. Vargas‐Inchaustegui, David J. Venzon, Irene Kalisz, Vaniambadi S. Kalyanaraman, Eun Mi Lee, Ranajit Pal et al. · 2013 · Virology
  56. Sleeping Beauty transposon vectors for therapeutic applications: advances and challenges
    Suneel A. Narayanavari, Zsuzsanna Izsvák · 2017 · Cell and Gene Therapy Insights
  57. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice
    Yunpu Wu, Dawei Yang, Bangfeng Xu, Wenhua Liang, Jinyu Sui, Yan Chen, Huanliang Yang, Hualan Chen, Ping Wei, Chuanling Qiao · 2017 · Antiviral Research
  58. Influence of method of systemic administration of adenovirus on virus-mediated toxicity: Focus on mortality, virus distribution, and drug metabolism
    Michael P. Boquet, Piyanuch Wonganan, Joseph D. Dekker, Maria A. Croyle · 2008 · Journal of Pharmacological and Toxicological Methods
  59. Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation
    Irene de Lázaro, Kostas Kostarelos · 2015 · Stem Cell Reviews and Reports
  60. Glucose intolerance and diabetes following antigen-specific insulitis in diabetes-susceptible “humanized” transgenic mice
    Raya B. Elagin, Juan Carlos Jaume · 2010 · Biochemical and Biophysical Research Communications
  61. Gene-Based Therapies for Cancer
    Jack A. Roth · 2010 · Springer eBooks
  62. Late generation lentiviral vectors: Evaluation of inflammatory potential in human airway epithelial cells
    Elena Copreni, Elena Nicolis, Anna Tamanini, Valentino Bezzerri, Stefano Castellani, Lucia Palmieri, Maria Grazia Giri, Antonio Vella, Marco Colombatti, Paolo Rizzotti et al. · 2009 · Virus Research
  63. Gene and Cell Therapy for Heart Failure
    Ebo D. de Muinck · 2009 · Antioxidants and Redox Signaling
  64. A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan
    Hyun-Jin Shin, Luis H. Franco, Vidhya R. Nair, Angela C. Collins, Michael U. Shiloh · 2017 · PLoS ONE
  65. Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro
    Shouwen Du, Yinyue Jiang, Wang Xu, Jieying Bai, Mingyao Tian, Maopeng Wang, Yuhang Wang, Tingting Cao, Lina Song, Yuhang Jiang et al. · 2019 · International Journal of Biological Macromolecules
  66. Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022
    Wenpeng Song, Hao Wang, Xiaoyan Wang · 2023 · Heliyon
  67. Design of Lentivirally Expressed siRNAs
    Ying Poi Liu, Ben Berkhout · 2012 · Methods in molecular biology
  68. Enhanced Biosafety of the Sleeping Beauty Transposon System by Using mRNA as Source of Transposase to Efficiently and Stably Transfect Retinal Pigment Epithelial Cells
    Nina Harmening, Sandra Johnen, Zsuzsanna Izsvák, Zoltán Ivics, Martina Kropp, Thais Bascuas, Peter Walter, Andreas Kreis, Bojan Pajic, Gabriele Thumann · 2023 · Biomolecules
  69. Express in Vitro Plasmid Transfection Achieved with 16+ Asymmetric Peptide Dendrimers
    Prarthana V. Rewatkar, David P. Sester, Harendra S. Parekh, Marie‐Odile Parat · 2016 · ACS Biomaterials Science & Engineering
  70. Characterization of the complexation phenomenon and biological activity in vitro of polyplexes based on Tetronic T901 and DNA
    Adriana Cambón, Eva Villar‐Álvarez, Manuel Alatorre‐Meda, Alberto Pardo, Baltazar Hiram Leal-Martínez, Sílvia Barbosa, Pablo Taboada, Vı́ctor Mosquera · 2018 · Journal of Colloid and Interface Science
  71. Adenoviral Vectors in Veterinary Vaccine Development: Potential for Further Development
    Olasumbo Ndi, MARY D. BARTON, Thiru Vanniasinkam · 2013 · World Journal of Vaccines
  72. Theilovirus 3C Protease Cleaves the C-Terminal Domain of the Innate Immune RNA Sensor, Melanoma Differentiation–Associated Gene 5, and Impairs Double-Stranded RNA–Mediated IFN Response
    Masahiko Miyamoto, Toshiki Himeda, Kazuki Ishihara, Takako Okuwa, Daiki Kobayashi, Masaaki Nameta, Yu Karasawa, Benyapa Chunhaphinyokul, Yutaka Yoshida, Nobuyuki Tanaka et al. · 2023 · The Journal of Immunology
  73. Clinical and Translational Challenges in Gene Therapy of Cardiovascular Diseases
    Divya Pankajakshan, Devendra K. · 2013 · InTech eBooks
  74. Optimized Adenovirus-Antibody Complexes Stimulate Strong Cellular and Humoral Immune Responses against an Encoded Antigen in Naïve Mice and Those with Preexisting Immunity
    Jin Huk Choi, Joe Dekker, Stephen C. Schafer, J Cush John, C. E. Whitfill, Christopher S. Petty, Eid E. Haddad, Maria A. Croyle · 2011 · Clinical and Vaccine Immunology
  75. Transfection of TGF-β shRNA by Using Ultrasound-targeted Microbubble Destruction to Inhibit the Early Adhesion Repair of Rats Wounded Achilles Tendon In vitro and In vivo
    Songya Huang, Xi Xiang, Li Qiu, Liyun Wang, Bihui Zhu, Ruiqian Guo, Xinyi Tang · 2020 · Current Gene Therapy
  76. Poly (amido amine) dendrimer silences the expression of epidermal growth factor receptor and p53 gene in vitro
    Alireza Nomani · 2012 · African Journal of Pharmacy and Pharmacology
  77. NAHEMS Guidelines: Vaccination for Contagious Diseases, Appendix A: Foot-and-Mouth Disease
    Anna Rovid Spickler, James A. Roth · 2015 · Iowa State University Digital Repository (Iowa State University)
  78. Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination
    Dionisia Marie Quiroga, Yasser Ali Aldhamen, Daniel M. Appledorn, Sarah Godbehere, Andrea Amalfitano · 2015 · Cancer Immunology Immunotherapy
  79. CpG ODN delivery systems based on nanomaterials
    Chunhai Fan, Qing Huang, Min WEI, Jiang LI, Nan Chen · 2014 · Chinese Science Bulletin (Chinese Version)
  80. FMD Vaccine Surge Capacity for Emergency Use in the United States
    James A. Roth, Anna Rovid Spickler · 2014 · Iowa State University Digital Repository (Iowa State University)
  81. Adenovirus as Tools in Animal Health
    José Manuel Rojas, Noemı́ Sevilla, Verónica Martı́n · 2019 · IntechOpen eBooks
  82. Vectors for gene therapy: A place for DNA transposon
    Benoı̂t Chénais · 2013 · Open Journal of Genetics
  83. “The Good, the Bad and the Ugly”: Interplay of Innate Immunity and Inflammation
    Mercedes Alemán · 2022 · Cellular Microbiology
  84. Isolation of Viral DNA from Cultures
    Larry A. Hanson · 2009 · CRC Press eBooks
  85. Adenovirus-Mediated CRM197 Sensitizes Human Glioma Cells to Gemcitabine by the Mitochondrial Pathway
    Lv-Xia Dai, Jing Yang, Jianmin Liu, Sizhou Huang, Baoning Wang, Hong Li, Jie Yang, Zhongyi Zhao, Kang Cao, Mingyuan Li · 2018 · Cancer Biotherapy and Radiopharmaceuticals
  86. 12-Crown-4-based amphipathic lipid and corresponding metal cation complexes for gene therapy applications: FT-IR characterization and surface charge determination
    P. Bruni, Vincenzo Fino, Michela Pisani, Giovanni Tosi, Pierluigi Stipa, P. Ferraris, Oriano Francescangeli · 2008 · Journal of Molecular Structure
  87. Inflammatory and cytotoxic mediators in COVID-19 patients and in ChAdOx1 nCoV-19 (AZD1222) vaccine recipients
    Débora Familiar-Macedo, Paulo Vieira Damasco, Víctor Fiestas Solórzano, Joyce Carnevale Rodrigues, Elba Regina Sampaio de Lemos, Flávia Barreto dos Santos, Marilda Mendonça Siqueira, Elzinandes Leal de Azeredo, Luzia Maria de‐Oliveira‐Pinto · 2023 · Cytokine
  88. Infrared Light Activated Highly Efficient Cell Therapy Using Flower‐Shaped Microstructure Device
    Ashwini Surendra Shinde, Pallavi Shinde, Moeto Nagai, Srabani Kar, Tuhin Subhra Santra · 2024 · Advanced Therapeutics
  89. Nanoelectroporation and controllable intracellular delivery into localized single cell with high transfection and cell viability
    Tuhin Subhra Santra, Jayant Borana, Pen‐Cheng Wang, Fan‐Gang Tseng · 2014 · IEEE International Conference on Micro Electro Mechanical Systems (MEMS)
  90. In vitro construction of tissue-engineered bone with bone morphogenetic protein-2-transfected rabbit bone marrow mesenchymal stem cells and hydroxyapatite nanocomposite
    Chunlei He, Cheng He, Jianwen Mo, Xiaona Fan, Guanglin Ji, Wuyang Liu, Dongbao Wu, Weimin Zhu, Daping Wang, Hui Gao · 2013 · Biomedizinische Technik/Biomedical Engineering
  91. NAHEMS Guidelines: Vaccination for Contagious Diseases
    James A. Roth, Amber Stumbaugh, Anna Rovid Spickler, Danelle A. Bickett-Weddle · 2014 · Iowa State University Digital Repository (Iowa State University)
  92. Recombinant adenovirus causes prolonged mobilization of macrophages in the anterior chambers of mice.
    Kacie J. Meyer, Danielle R. Pellack, Adam Hedberg‐Buenz, Nicholas Pomernackas, Dana A. Soukup, Kai Wang, John H. Fingert, Michael G. Anderson · 2021 · PubMed Central
  93. Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses
    Dionisia Marie Quiroga, Yasser Ali Aldhamen, Sarah Godbehere, Laura Harding, Andrea Amalfitano · 2017 · Clinical and Vaccine Immunology
  94. Oxford–AstraZeneca COVID-19 Vaccine (AZD1222), an Approved, Non-Replicating Chimpanzee Adenovirus-Vectored Vaccine for the COVID-19 Pandemic
    Chuchu Guo · 2021
  95. Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector
    Enkhjin Saruuldalai, Hwi‐Ho Lee, Yeon-Su Lee, Eun Kyung Hong, Soyoun Ro, Yeochan Kim, TaeJin Ahn, Jong‐Lyul Park, Seon‐Young Kim, Seung-Pil Shin et al. · 2024 · Molecular Therapy — Nucleic Acids
  96. Photobiomodulation of Blue Light Enhance Melanoma Cellular Recovery Following Viral Infection via Mitochondrial Pathways
    Haokuan Qin, Hui Jiang, Shijie Huang, Jiali Yang, Qiqi Fu, Ruixiao Zhang, Zeqing Chen, Muqing Liu · 2025 · Journal of Biophotonics
  97. Nonviral gene therapy for age-related macular degeneration
    Gabriele Thumann · 2011 · Expert Review of Ophthalmology
  98. NON-CONDENSING POLYMERIC GENE DELIVERY SYSTEMS: PRINCIPLES AND APPLICATIONS
    Shardool Jain, Husain Z. Attarwala, Mansoor M. Amiji · 2010 · Nano LIFE
  99. Methods to Mitigate Immune Responses to Adenoviral Vectors
    Yasser Ali Aldhamen, Andrea Amalfitano · 2016 · Elsevier eBooks
  100. The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa
    Bitrus Yakubu, J Nok Andrew, Olajide A. Owolodun, Pam Dachung Luka, Dunkura Ali Umaru · 2015 · Biotechnology and Molecular Biology Reviews